| RS2471727531 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471727605 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Brugada syndrome |
| RS2471728089 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS2471728666 |
THRB
|
Health Risk |
Likely pathogenic |
Thyroid hormone resistance, generalized |
| RS2471729239 |
THRB
|
Health Risk |
Conflicting classifications of pathogenicity |
THRB-related disorder, THRB-related disorder |
| RS2471733263 |
HESX1
|
Health Risk |
Pathogenic |
Septo-optic dysplasia sequence, Septo-optic dysplasia sequence |
| RS2471733937 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471733954 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471733960 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471737125 |
HESX1
|
Health Risk |
Pathogenic |
— |
| RS2471740178 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471740235 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471740271 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471740291 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471740325 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471744785 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471744858 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face |
| RS2471744884 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471744989 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471744994 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471745030 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471745691 |
SCN5A
|
Health Risk |
Pathogenic |
Long QT syndrome 3, Long QT syndrome 3 |
| RS2471747786 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471748093 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471748797 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471749816 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2471754193 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Brugada syndrome |
| RS2471754528 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Brugada syndrome |
| RS2471754553 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2471754589 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471754892 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2471762530 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471763081 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471763175 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471763320 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471766771 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471766903 |
QRICH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2471767329 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471772220 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471775554 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471775566 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471783321 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471783330 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471785512 |
FANCE
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS2471785963 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471786478 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471786494 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471787771 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471787843 |
POU1F1
|
Health Risk |
Likely pathogenic |
— |
| RS2471793457 |
ROBO1
|
Health Risk |
Likely pathogenic |
— |
| RS2471793778 |
PROS1
|
Health Risk |
Likely pathogenic |
— |
| RS2471793821 |
PROS1
|
Health Risk |
Likely pathogenic |
Protein S deficiency disease, Protein S deficiency disease |
| RS2471793830 |
PROS1
|
Health Risk |
Likely pathogenic |
— |
| RS2471793974 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS2471801299 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471801949 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2471802453 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471802474 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471802644 |
POU1F1
|
Health Risk |
Likely pathogenic |
— |
| RS2471803456 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS2471803949 |
TTN
|
Health Risk |
Likely pathogenic |
Early-onset myopathy with fatal cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471807073 |
POU1F1
|
Health Risk |
Likely pathogenic |
— |
| RS2471807189 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471807594 |
POU1F1
|
Health Risk |
Pathogenic |
— |
| RS2471816852 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471816999 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471817112 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471822309 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471822311 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471822543 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2471826054 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471826221 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2471826563 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2471826564 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471828509 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2471838167 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471839050 |
SCN5A
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2471839510 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471844538 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471848000 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471848165 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471848482 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471852020 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471852703 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471856206 |
QARS1
|
Health Risk |
Likely pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471859404 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471863066 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471864436 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471864491 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471864589 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471867142 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471867217 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS2471888911 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471890417 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471895234 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2471904012 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2471904945 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471907076 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471917414 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471917592 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |